These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 25132452)
21. Circulating Treg cells from patients with cerebral aneurysms displayed deficiency in ICOS expression and function. Zhao MG; Peng C; Li LM; Chen L; Zhang HF Clin Exp Pharmacol Physiol; 2020 Dec; 47(12):1923-1931. PubMed ID: 32726458 [TBL] [Abstract][Full Text] [Related]
22. Responses of CD4(+) CD25(+) Foxp3(+) and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children. Lou W; Wang C; Wang Y; Han D; Zhang L Pediatr Allergy Immunol; 2012 Mar; 23(2):140-9. PubMed ID: 22192331 [TBL] [Abstract][Full Text] [Related]
23. Identification of regulatory T cells during experimental Leishmania infantum infection. Rodrigues OR; Marques C; Soares-Clemente M; Ferronha MH; Santos-Gomes GM Immunobiology; 2009; 214(2):101-11. PubMed ID: 19167988 [TBL] [Abstract][Full Text] [Related]
24. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115 [TBL] [Abstract][Full Text] [Related]
25. Characterization of novel CD8 Fan JN; Ho H; Chiang BL Cell Mol Life Sci; 2024 Aug; 81(1):327. PubMed ID: 39085655 [TBL] [Abstract][Full Text] [Related]
26. PD-1 and ICOS counter-regulate tissue resident regulatory T cell development and IL-10 production during flu. McGee MC; Zhang T; Magazine N; Islam R; Carossino M; Huang W Front Immunol; 2022; 13():984476. PubMed ID: 36159872 [TBL] [Abstract][Full Text] [Related]
27. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Ito T; Hanabuchi S; Wang YH; Park WR; Arima K; Bover L; Qin FX; Gilliet M; Liu YJ Immunity; 2008 Jun; 28(6):870-80. PubMed ID: 18513999 [TBL] [Abstract][Full Text] [Related]
28. ICOS Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099 [TBL] [Abstract][Full Text] [Related]
29. Nonclassical CD4+CD49b+ Regulatory T Cells as a Better Alternative to Conventional CD4+CD25+ T Cells To Dampen Arthritis Severity. Vicente R; Quentin J; Mausset-Bonnefont AL; Chuchana P; Martire D; Cren M; Jorgensen C; Louis-Plence P J Immunol; 2016 Jan; 196(1):298-309. PubMed ID: 26590312 [TBL] [Abstract][Full Text] [Related]
30. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. Pyzik M; Piccirillo CA J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784 [TBL] [Abstract][Full Text] [Related]
31. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4. Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658 [TBL] [Abstract][Full Text] [Related]
32. Immunomodulation of human CD19 Hong M; Liao Y; Liang J; Chen X; Li S; Liu W; Gao C; Zhong Z; Kong D; Deng J; Zhang J; Pan G Hum Immunol; 2019 Oct; 80(10):863-870. PubMed ID: 31262519 [TBL] [Abstract][Full Text] [Related]
33. Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease. Alfen JS; Larghi P; Facciotti F; Gagliani N; Bosotti R; Paroni M; Maglie S; Gruarin P; Vasco CM; Ranzani V; Frusteri C; Iseppon A; Moro M; Crosti MC; Gatti S; Pagani M; Caprioli F; Abrignani S; Flavell RA; Geginat J J Allergy Clin Immunol; 2018 Nov; 142(5):1537-1547.e8. PubMed ID: 29369775 [TBL] [Abstract][Full Text] [Related]
36. Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells. Hall BM; Tran GT; Robinson CM; Hodgkinson SJ Int Immunopharmacol; 2015 Oct; 28(2):875-86. PubMed ID: 25882104 [TBL] [Abstract][Full Text] [Related]
37. Plasma Cell Alloantigen 1 and IL-10 Secretion Define Two Distinct Peritoneal B1a B Cell Subsets With Opposite Functions, PC1 Schumacher A; Ehrentraut S; Scharm M; Wang H; Hartig R; Morse HC; Zenclussen AC Front Immunol; 2018; 9():1045. PubMed ID: 29868008 [TBL] [Abstract][Full Text] [Related]
38. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit. Sun JB; Flach CF; Czerkinsky C; Holmgren J J Immunol; 2008 Dec; 181(12):8278-87. PubMed ID: 19050244 [TBL] [Abstract][Full Text] [Related]
39. Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells. Prochazkova J; Fric J; Pokorna K; Neuwirth A; Krulova M; Zajicova A; Holan V Immunology; 2009 Sep; 128(1 Suppl):e670-8. PubMed ID: 19740328 [TBL] [Abstract][Full Text] [Related]
40. CXCL10 treatment promotes reduction of IL-10 Eufrásio de Figueiredo WM; Heredia FF; Santos AS; da Rocha Braga R; Marciano Fonseca FR; Lúcia de Castro Rodrigues N; Abreu TM; Maria de Lima Pompeu M; Barbosa HS; Teixeira MJ Exp Parasitol; 2019 Dec; 207():107789. PubMed ID: 31669169 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]